PRNCR1 and neoplasm: We further analyzed the impact of PRNCR1 polymorphisms on GC risk in combination with various characteristics and clinical features, including age, sex, tumor differentiation, histologic type, T classification, lymph node metastasis (LNM), and tumor stage.